Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 
Our years of experiences and expertise have made us renowned and reliable Service providers to clinical research industry.
"When you work as organized team, then best results are obtained ".

Following this, we always go a step further to become our clients’ ultimate partner in their study, to precisely understand their requirements and provide optimal solutions.

We use our extensive experience along with the appropriate approach for working in INDIA in order to achieve resultsthat exceed the expectations.Our professional expertise covers advisory activities, planning and analysis of clinical trials.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 

Investigational Sites Investigators
Sponsors Contract Research Organisation
Site Management Organisation Clinical Research Coordinator
Clinical Trial Legal Services Auditing

Find Us On:

 INDIA:
 OSSINC.
 OSSINC INDIA(OSSINC)

 A 48 Raja JI Puram
 Lucknow 226017
 Uttar Pradesh
 Phone: +91-9838172269
               +91-7379737763
               +91-9889023231

 Fax: +91-522-4012214
 LL: +91-522-4012212
 Email: bd@ossinc.org , contact@ossinc.org

 U.S.A:
 OSS Research International INC.,
 5348, Vegas Dr., Las Vegas,
 NV 891082347,
 U.S.A.
 Email: info@ossresearchinternational.com

Sanofi Pasteur and International Vaccine Institute Partner against Dengue

ONGLYZA™ US label update regarding use in renally impaired adults with type 2 diabetes

European Medicines Agency reviews further data on narcolepsy and possible association with Pandemrix

Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right

New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin

India's Drug Technical Advisory Board (DTAB) has decided to ban two controversial drugs - Gatifloxacine and Tegaserod - because of their side-effects

MoH bans nimesulide suspension, cisapride, phenylpropanolamine, human placenta extracts, Sibutramine and R-Sibutramine

   Strict Protocol and GCP compliance.
   Building up long-term client partnership.
   All clinical research solutions under one roof.
   Quality compliance and completion of studies with specified timelines.
   Flexible and customized approach with our unique Client Representative System.
   Network of Investigators and coordinators in urban and suburban population of india.
   Feasibility response in less than three days.
   A separate network of Investigators in various Institute and medical colleges of India.
Find Us on:
Home | About Us | Contact Us | Services | Network Partners | Resources | Regulatory Services | Institute | Therapeutic area

Copyright©. All right reserved. Powered By: SKARTIA